Variable implementation of optimal therapeutic strategies in metastatic colorectal cancer: Reviewing rates of liver resection and triplet chemotherapy across Australian hospitals as potential quality indicators.
Catherine Dunn, Lucy Gately, Jeanne Tie, Louise M Nott, Belinda Lee, Shehara Ramyalini Mendis, Jeremy David Shapiro, Vanessa Wong, Matthew E Burge, Rachel Wong, Suzanne Kosmider, Margaret Lee, Ross Jennens, Peter Gibbs
Journal of Clinical Oncology | American Society of Clinical Oncology (ASCO) | Published : 2021
248 Background: Quality indicators (QI) are essential to monitor the efficacy of cancer care and to guide quality improvement, however many are derived from ‘expert consensus’ and are not validated against outcomes. Moreover, the majority of oncological QI are defined in the surgical setting, with only a paucity of QI for the treatment of metastatic disease. We aimed to define and validate novel QI for metastatic colorectal cancer (mCRC) based on therapeutic approaches associated with a proven survival benefit. Methods: Data was analysed from TRACC, a multisite Australian registry collecting prospective demographic, tumour, treatment and outcome data for mCRC. We identified all patients dia..View full abstract